Dendreon Corp fka DNDNQ

[scha6ab]

Assuming this is in fact an approvable scenario, dont you think this bodes well for DNDN? That possibly there is either some minor clarification on their part or they need time to complete enrollment. Which the news today from the AUA would definitely help that cause, as well as upcoming ASCO publicity. If this is the case how can the analysts who are so called "experts" in biotech not pick up on this? It sounds to me that they are purporting this to be more in the major deficiency camp, but how can the lines be blurred on this classification. I am a so very confused on this point, who do you believe. The two we need to hear from DNDN and FDA are understandably on self-imposed gag orders until next month. I guess we'll just have to wait and see.